A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
Main Authors: | Jensen K, Ranganathan UD, Kozlowski P, Van Rompay K, Canfield D, Ravindran R, Khan I, Luciw P, Fennelly G, Larsen M, Abel K |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | Retrovirology |
Similar Items
-
SIV Evolutionary Dynamics in Cynomolgus Macaques during SIV-<i>Mycobacterium tuberculosis</i> Co-Infection
by: Kaho H. Tisthammer, et al.
Published: (2021-12-01) -
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
by: Van Rompay K, et al.
Published: (2009-10-01) -
Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017-12-01) -
Antibody glycosylation correlates with disease progression in SIV‐Mycobacterium tuberculosis coinfected cynomolgus macaques
by: Ebene R Haycroft, et al.
Published: (2023-01-01) -
Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells
by: Hamimi C, et al.
Published: (2012-09-01)